They showed anti-tumor effect against triple-negative breast cancer (TNBC), highlighting the promise of HSP90 CTIs for TNBC therapy.449–451 Deguelin, a naturally occurring rotenoid, is another important class of CTIs. Here, HSP90AA1 is linked to neoplasm.